Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
Status:
Completed
Trial end date:
2019-03-11
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, parallel-group trial to confirm the clinical efficacy and safety
of dasiglucagon in the rescue treatment of hypoglycemia in subjects with type 1 diabetes
mellitus (T1DM) compared to placebo